In this setting, following CCL2 secretion, pre-malignant hepatocytes were cleared by recruited CCR2+ pro-inflammatory MoMFs, thereby preventing HCC initiation [371,372]. The gene discussed is CCR2; the disease is hepatocellular carcinoma.